Galantamine
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151510This classification denotes an acetylcholinesterase inhibitor with the molecular formula C17H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0D3Q044KCA, chemically known as 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4as-(4a.alpha.,6.beta.,8ar*))- but generally known as galantamine, which bears US NIH Compound Identifier 3449. European Medicines Agency schedules Galantamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07870MIG. The term GALANTAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules galantamine in its Anatomical Therapeutic Chemical (ATC) Classification. GALANTAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule galantamine under HS 29399900 and SITC 54149. As of Q4 2014, GALANTAMINE remains the US FDA Preferred Term for this commodity. Galantamine bears US NLM identifiers UMLS ID C0016967 and NCI Concept Code C65797. SMILES: O1C2C3(C4C1C(OC)CCC4CN(CC3)C)C=CC(O)C2.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.